1. Zhao, Shuai, Zhang, Yichi, Lu, Xiuqin, Chen, Shuxian, Wang, Jian. 2021. CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2/Bax pathway. In International journal of biological sciences, 17, 3608-3621. doi:10.7150/ijbs.64003. https://pubmed.ncbi.nlm.nih.gov/34512169/
2. Liu, Zhenbin, Pei, Mengyuan, Liu, Geng, Ma, Zhongren, Yang, Xiaoming. 2023. CDC20 is a potential target gene to inhibit the tumorigenesis of MDCK cells. In Biologicals : journal of the International Association of Biological Standardization, 83, 101697. doi:10.1016/j.biologicals.2023.101697. https://pubmed.ncbi.nlm.nih.gov/37579524/
3. Guo, Lianxia, Cen, Haobin, Weng, Jiaxian, Chen, Zhiyong, Wu, Baojian. 2023. PER2 integrates circadian disruption and pituitary tumorigenesis. In Theranostics, 13, 2657-2672. doi:10.7150/thno.82995. https://pubmed.ncbi.nlm.nih.gov/37215573/
4. Zhang, Yunqiu, Li, Jiuyi, Yi, Kaikai, Jiang, Tao, Fan, Xiaolong. 2019. Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in glioma. In Proceedings of the National Academy of Sciences of the United States of America, 116, 6975-6984. doi:10.1073/pnas.1814060116. https://pubmed.ncbi.nlm.nih.gov/30877245/
5. Lai, Xing, Wu, Ya-Kun, Hong, Guo-Qing, Liu, Shuang-Quan, Feng, Hua-Guo. 2022. A Novel Gene Signature Based on CDC20 and FCN3 for Prediction of Prognosis and Immune Features in Patients with Hepatocellular Carcinoma. In Journal of immunology research, 2022, 9117205. doi:10.1155/2022/9117205. https://pubmed.ncbi.nlm.nih.gov/35402624/
6. Feng, Zhenyu, Zhang, Ningning, Wang, Liang, Xie, Yunpeng, Xia, Yun-Long. 2025. CDC20 protects the heart from doxorubicin-induced cardiotoxicity by modulating CCDC69 degradation. In Cellular & molecular biology letters, 30, 29. doi:10.1186/s11658-025-00708-8. https://pubmed.ncbi.nlm.nih.gov/40045239/
7. Chen, Yingtong, Yang, Ping, Wang, Jing, Ke, Xiaoyan, Jing, Hongmei. 2023. p53 directly downregulates the expression of CDC20 to exert anti-tumor activity in mantle cell lymphoma. In Experimental hematology & oncology, 12, 28. doi:10.1186/s40164-023-00381-7. https://pubmed.ncbi.nlm.nih.gov/36882855/
8. Li, Lin, Lei, Qingsong, Zhang, Shujun, Kong, Lingna, Qin, Bo. 2017. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis. In Oncology reports, 38, 2607-2618. doi:10.3892/or.2017.5946. https://pubmed.ncbi.nlm.nih.gov/28901457/
智鼠故事 
